Accelerating Study Design Decisions with Real‑World Data
Designing a clinical study has never been more complex—or more consequential. As protocols grow increasingly restrictive and timelines tighten, early design decisions can determine whether a study launches smoothly or struggles with amendments, delays, and...
Patient-Centricity at the Point of Care: A Clinician’s Perspective on Rethinking Trials
When I think about the phrase “patient-centricity,” I often pause. It’s everywhere in our industry: clinical trial brochures, conference panels, even corporate mission statements. But too often, it risks becoming a buzzword rather than a lived reality. In our...
TriNetX Named Best of Show Finalist at SCOPE: Advancing Clinical Trial Planning with Conversational AI and Enhanced API Capabilities
TriNetX is proud to announce that we were named a Best of Show Finalist at SCOPE, the summit for clinical ops executives, one of the industry’s premier events focused on advancing clinical operations and innovation. This recognition highlights our continued commitment...
Insights from the Healthcare System for Patient-Centric Trials at the Point of Care
Patient-centricity is everywhere in clinical research. But what does it actually look like inside real healthcare systems? In this episode of Inside the Trends, we move beyond theory to explore how clinical trials can truly align with the realities of patient...
Finding the Unfindable: How One Healthcare Organization is Using TriNetX to Identify Underdiagnosed Heart Disease
We’re proud to announce Worcestershire Acute Hospitals NHS Trust as our Q1 2026 Network Spotlight winner! Led by Dr. David Wilson, Consultant Cardiologist at Worcestershire Acute Hospitals NHS Trust, a groundbreaking quality improvement project is demonstrating how...
TriNetX Unveils Conversational AI Interface and Enhanced API Capabilities
Success achieved in reducing trial costs and timelines drives 2026 platform enhancements designed to democratize clinical research analytics. CAMBRIDGE, Mass., January 22, 2026 — TriNetX, driven by its vision of a connected world where data and intelligence power...
The Year Real-World Data Became Essential: The Resources That Captivated Our Community in 2025
As we step into 2026, the biopharma industry finds itself at a different starting line than anyone predicted just a year ago. As Director of Content & Communication at TriNetX, I’ve watched which resources captivated our community in 2025, and more...
Winning with RWE: What It Takes to Make Real-World Evidence Submission-Ready
When every respondent in a survey agrees, it’s more than a trend; it’s a mandate. In the 2025 TriNetX and studioID survey of 150 senior biopharma executives, all participants agreed that real-world evidence (RWE) has the potential to improve regulatory submissions....